Merkel Cell Carcinoma Overview

Save information for later
Sign Up

Learn About Merkel Cell Carcinoma

What is the definition of Merkel Cell Carcinoma?
Merkel cell carcinoma (MCC) is a rare, aggressive skin cancer. It usually develops as a single, painless, bump on sun-exposed skin. The bump may be skin-colored or red-violet, and tends to grow rapidly over weeks to months. It may spread quickly to surrounding tissues, nearby lymph nodes, or more distant parts of the body. Factors associated with developing MCC include increasing age, fair skin, a history of extensive sun exposure, chronic immune suppression, and the Merkel cell polyomavirus. The Merkel cell polyomavirus has been detected in most people who have MCC.
What are the alternative names for Merkel Cell Carcinoma?
  • Merkel cell carcinoma
  • Carcinoma, merkel cell
  • Cutaneous neuroendocrine carcinoma
  • Merkel cell cancer
  • Merkle tumors
Who are the top Merkel Cell Carcinoma Local Doctors?
Vernon K. Sondak
Elite in Merkel Cell Carcinoma
Dr. Vernon K. Sondak
General Surgery
Elite in Merkel Cell Carcinoma
Dr. Vernon K. Sondak
General Surgery

H Lee Moffitt Cancer Ctr And Res Inst Life Time Cancer Scrn Ctr Inc

12902 Usf Magnolia Dr, 
Tampa, FL 
888-860-2778
Languages Spoken:
English
See accepted insurances
Accepting New Patients
Offers Telehealth

Vernon Sondak is a General Surgeon in Tampa, Florida. Dr. Sondak and is rated as an Elite provider by MediFind in the treatment of Merkel Cell Carcinoma. His top areas of expertise are Melanoma, Merkel Cell Carcinoma, Neuroendocrine Tumor, Lymphofollicular Hyperplasia, and Lymphadenectomy. Dr. Sondak is currently accepting new patients.

Guilherme Rabinowits
Elite in Merkel Cell Carcinoma
Dr. Guilherme Rabinowits
Oncology | Hematology Oncology | Hematology
Elite in Merkel Cell Carcinoma
Dr. Guilherme Rabinowits
Oncology | Hematology Oncology | Hematology

H Lee Moffitt Cancer Ctr And Res Inst Life Time Cancer Scrn Ctr Inc

12902 Usf Magnolia Dr, 
Tampa, FL 
888-860-2778
Languages Spoken:
English
See accepted insurances
Accepting New Patients
Offers Telehealth

Guilherme Rabinowits is an Oncologist and a Hematologist Oncology provider in Tampa, Florida. Dr. Rabinowits and is rated as an Elite provider by MediFind in the treatment of Merkel Cell Carcinoma. His top areas of expertise are Merkel Cell Carcinoma, Head and Neck Squamous Cell Carcinoma (HNSCC), Neuroendocrine Tumor, and Tongue Cancer. Dr. Rabinowits is currently accepting new patients.

 
 
 
 
Learn about our expert tiers
Learn More
Elite in Merkel Cell Carcinoma
Dr. Jeffrey M. Farma
General Surgery
Elite in Merkel Cell Carcinoma
Dr. Jeffrey M. Farma
General Surgery

Temple Faculty Practice Plan Inc

3401 N Broad St, 
Philadelphia, PA 
215-707-3326
Languages Spoken:
English
See accepted insurances

Jeffrey Farma is a General Surgeon in Philadelphia, Pennsylvania. Dr. Farma and is rated as an Elite provider by MediFind in the treatment of Merkel Cell Carcinoma. His top areas of expertise are Melanoma, Merkel Cell Carcinoma, Adult Soft Tissue Sarcoma, Gastrostomy, and Lymphadenectomy.

View All Doctors
What are the latest Merkel Cell Carcinoma Clinical Trials?
Studies of Dermatologic Diseases-Biospecimen Acquisition Protocol
Studies of Dermatologic Diseases-Biospecimen Acquisition Protocol
Enrollment Status: Recruiting
Publish Date: February 25, 2025

Background: - Skin disease can have many causes. It can have widespread consequences, and in rare cases can lead to death. Researchers want to determine the causes of various types of skin diseases and find a way to treat them.

Match to trials
Find the right clinical trials for you in under a minute
Get started
A Phase I Trial of CRD3874-SI, a STING Agonist, in Patients With Advanced/Metastatic Malignant Solid Tumors
A Phase I Trial of CRD3874-SI, a STING Agonist, in Patients With Advanced/Metastatic Malignant Solid Tumors
Enrollment Status: Recruiting
Publish Date: February 24, 2025
Intervention Type: Drug
Study Phase: Phase 1

Summary: This study will test the safety of a study drug called CRD3874-SI. The researchers will test different doses of CRD3874-SI to find the highest dose that causes few or mild side effects in participants. After the researchers find the highest safe dose of CRD3874-SI, they will test that dose in new groups of participants to help them learn more about the side effects of the study drug and find out w...

View All Clinical Trials
Who are the sources who wrote this article ?

Published Date: May 02, 2022
Published By: Genetic and Rare Diseases Informnation Center